Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EW.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBPNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.256NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.77NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.248NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.70NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.559NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.69NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ER.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.640NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.6 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.9 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XUNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.3 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.16.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.372NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.425NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.144NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.288NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.249NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.439NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.408NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.256NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.7 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used